SCHEMBL28210679

SCHEMBL28210679

OCc1cccc(-c2cccnc2)c1F

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 1/20 0.49
▸ MKNK2 Q9HBH9 1/20 0.49
▸ KCNA5 P22460 3/20 0.48
▸ GAA P10253 1/20 0.47
▸ CYP11B1 P15538 6/20 0.47
▸ CYP11B2 P19099 5/20 0.47
▸ CYP17A1 P05093 3/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2A6 P11509 4/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ NR4A2 P43354 1/20 0.43
▸ PDCD1 Q15116 1/20 0.42
▸ CD274 Q9NZQ7 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ PDK2 Q15119 1/20 0.41
▸ USP1 O94782 1/20 0.40
▸ WDR48 Q8TAF3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28210685 0.85 NR4A2 (0.44) KCNA5CYP2A6NR4A2PDCD1CD274
SCHEMBL477395 0.82 KCNA5 (0.61) MKNK1MKNK2KCNA5GAACYP11B1
SCHEMBL30790364 0.82 PDCD1 (0.60) ALDH1A1NR4A2PDCD1CD274PDK2
SCHEMBL9548114 0.82 PDCD1 (0.60) ALDH1A1NR4A2PDCD1CD274PDK2
SCHEMBL30091380 0.80 PDCD1 (0.69) MKNK1MKNK2KCNA5GAACYP11B1
SCHEMBL11074941 0.80 PDCD1 (0.69) MKNK1MKNK2KCNA5GAACYP11B1
SCHEMBL10966421 0.79 KCNA5 (0.54) MKNK1MKNK2KCNA5GAACYP11B1
SCHEMBL19923153 0.78 PDCD1 (0.47) NR4A2PDCD1CD274PDK2
SCHEMBL28997762 0.77 CYP11B1 (0.55) MKNK1MKNK2CYP11B1CYP11B2CYP17A1
SCHEMBL5144683 0.77 CYP2A6 (0.58) MKNK1MKNK2KCNA5GAACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922379-A Substituted guanidine derivatives 宇部兴产株式会社 2018-04-17 — — CN disclosed
Send feedback